BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36493943)

  • 21. Nephrotoxic Effect of Aspartame as an Artificial Sweetener: a Brief Review.
    Ardalan MR; Tabibi H; Ebrahimzadeh Attari V; Malek Mahdavi A
    Iran J Kidney Dis; 2017 Oct; 11(5):339-343. PubMed ID: 29038387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity and genotoxicity studies of aspartame.
    Otabe A; Ohta F; Takumi A; Lynch B
    Regul Toxicol Pharmacol; 2019 Apr; 103():345-351. PubMed ID: 29408486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advantame--an overview of the toxicity data.
    Otabe A; Fujieda T; Masuyama T; Ubukata K; Lee C
    Food Chem Toxicol; 2011 Nov; 49 Suppl 1():S2-7. PubMed ID: 22036024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.
    Berry C; Brusick D; Cohen SM; Hardisty JF; Grotz VL; Williams GM
    Nutr Cancer; 2016; 68(8):1247-1261. PubMed ID: 27652616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspartame and Soft Drink-Mediated Neurotoxicity in Rats: Implication of Oxidative Stress, Apoptotic Signaling Pathways, Electrolytes and Hormonal Levels.
    Lebda MA; Sadek KM; El-Sayed YS
    Metab Brain Dis; 2017 Oct; 32(5):1639-1647. PubMed ID: 28660358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspartame, low-calorie sweeteners and disease: regulatory safety and epidemiological issues.
    Marinovich M; Galli CL; Bosetti C; Gallus S; La Vecchia C
    Food Chem Toxicol; 2013 Oct; 60():109-15. PubMed ID: 23891579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sweetening agent aspartame as carcinogen?].
    Kinderkrankenschwester; 2006 Feb; 25(2):82. PubMed ID: 16604954
    [No Abstract]   [Full Text] [Related]  

  • 28. Comprehensive investigation evaluating the carcinogenic hazard potential of acetaminophen.
    Sirois JE
    Regul Toxicol Pharmacol; 2021 Jul; 123():104944. PubMed ID: 33933547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspartame-induced apoptosis in PC12 cells.
    Horio Y; Sun Y; Liu C; Saito T; Kurasaki M
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):158-65. PubMed ID: 24355796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspartame bioassay findings portend human cancer hazards.
    Huff J; LaDou J
    Int J Occup Environ Health; 2007; 13(4):446-8. PubMed ID: 18085058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of potential carcinogenicity for steviol glycosides - Systematic evaluation and integration of mechanistic data into the totality of evidence.
    Chappell GA; Heintz MM; Borghoff SJ; Doepker CL; Wikoff DS
    Food Chem Toxicol; 2021 Apr; 150():112045. PubMed ID: 33587976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter to U.S. FDA commissioner. Questions about the safety of the artificial sweetener aspartame.
    Abdo KM; Camargo CA; Davis D; Egilman D; Epstein SS; Froines J; Hattis D; Hooper K; Huff J; Infante PF; Jacobson MF; Teitelbaum DT; Tickner JA
    Int J Occup Environ Health; 2007; 13(4):449-50. PubMed ID: 18085059
    [No Abstract]   [Full Text] [Related]  

  • 33. Consideration of the variability in control tumor incidence data at the Ramazzini Institute in evaluating treatment-related effects following chemical exposure.
    Gentry R; Greene T; Bartow H; Van Landingham C; Rodricks J; Clewell H
    Crit Rev Toxicol; 2024 Mar; 54(3):153-173. PubMed ID: 38470145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight of evidence analysis of the tumorigenic potential of 1,3-dichloropropene supports a threshold-based risk assessment.
    Yan ZJ; Bartels M; Gollapudi B; Driver J; Himmelstein M; Gehen S; Juberg D; van Wesenbeeck I; Terry C; Rasoulpour R
    Crit Rev Toxicol; 2020 Nov; 50(10):836-860. PubMed ID: 33528302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotoxicity of aspartame.
    Rencüzoğullari E; Tüylü BA; Topaktaş M; Ila HB; Kayraldiz A; Arslan M; Diler SB
    Drug Chem Toxicol; 2004 Aug; 27(3):257-68. PubMed ID: 15478947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinogenicity of aspartame in rats not proven.
    Magnuson B; Williams GM
    Environ Health Perspect; 2008 Jun; 116(6):A239-40; author reply A240. PubMed ID: 18560494
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspartame not linked to cancer.
    Abegaz EG
    Environ Health Perspect; 2007 Jan; 115(1):A16-7; author reply A17. PubMed ID: 17366802
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Aspartame as a sweetener.
    Olney JW
    N Engl J Med; 1975 Jun; 292(23):1244-5. PubMed ID: 1128585
    [No Abstract]   [Full Text] [Related]  

  • 40. Revisiting the safety of aspartame.
    Choudhary AK; Pretorius E
    Nutr Rev; 2017 Sep; 75(9):718-730. PubMed ID: 28938797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.